Scinovex
articleTop 1% cited

Prolonged n‐3 polyunsaturated fatty acid supplementation ameliorates hepatic steatosis in patients with non‐alcoholic fatty liver disease: a pilot study

Alimentary Pharmacology & Therapeutics · 2006 · Vol. 23(8) · pp. 1143–1151
M. CapanniFrancesca CalellaMaria Rosa BiaginiS. GeniseLaura RaimondiGiorgio BedogniGianluca Svegliati‐BaroniFrancesco SofiStefano MilaniRosanna AbbateC. SurrentiAlessandro Casini

Abstract

Supplementation with n-3 PUFA improves biochemical, ultrasonographic and haemodynamic features of liver steatosis. Our study supports the efficacy of n-3 PUFA as a new therapeutic approach in the treatment of NAFLD.

Liver Disease Diagnosis and TreatmentDiet, Metabolism, and DiseaseLiver Disease and TransplantationFatty liverInternal medicineMedicinePolyunsaturated fatty acidSteatosisTransaminaseGastroenterologySteatohepatitisAspartate transaminaseAlanine transaminase

MeSH terms

AdultAgedAlanine TransaminaseAspartate AminotransferasesBlood GlucoseFatty LiverFemalegamma-GlutamyltransferaseHumansLiverMaleMiddle AgedPilot ProjectsTriglyceridesFatty Acids, Omega-3

Funding

  • Sigma-Tau Pharmaceuticals
  • Ministero della Salute
Citations
408
FWCI
14.15
field-weighted impact
References
42
Percentile
99%
vs. same field & year
Citations per year
Citation Network

How this paper connects to the literature. Drag to explore, click any node to open that paper.